Effective diabetes complication management is a step toward a carbon-efficient planet: an economic modeling study.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
04 2020
Historique:
received: 31 10 2019
revised: 19 02 2020
accepted: 24 03 2020
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 22 6 2021
Statut: ppublish

Résumé

The management of diabetes-related complications accounts for a large share of total carbon dioxide equivalent (CO Using the IQVIA Core Diabetes Model, we estimated the impact of maintaining glycated hemoglobin (HbA Maintaining HbA When comparing people with untreated diabetes, maintaining glycemic control at 7% (53 mmol/mol) on a single agent or improving HbA

Sections du résumé

BACKGROUND
The management of diabetes-related complications accounts for a large share of total carbon dioxide equivalent (CO
METHODS
Using the IQVIA Core Diabetes Model, we estimated the impact of maintaining glycated hemoglobin (HbA
RESULTS
Maintaining HbA
CONCLUSIONS
When comparing people with untreated diabetes, maintaining glycemic control at 7% (53 mmol/mol) on a single agent or improving HbA

Identifiants

pubmed: 32299897
pii: 8/1/e001017
doi: 10.1136/bmjdrc-2019-001017
pmc: PMC7199151
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MC, MM, and LT have received personal fees and non-financial support from Novo Nordisk, NHS Sustainable Development Unit and IQVIA. UHP is an employee of Novo Nordisk AS.

Références

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii73-80
pubmed: 22815543
J Wound Care. 2002 Feb;11(2):70-4
pubmed: 11901743
Qual Health Care. 2000 Dec;9(4):257-63
pubmed: 11101711
N Engl J Med. 2006 Dec 7;355(23):2427-43
pubmed: 17145742
Diabetes Ther. 2017 Feb;8(1):129-147
pubmed: 28058656
Environ Health Perspect. 2011 Feb;119(2):A60-1
pubmed: 21288808
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Curr Med Res Opin. 2004 Aug;20 Suppl 1:S5-26
pubmed: 15324513
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Value Health. 2014 Sep;17(6):714-24
pubmed: 25236995
Diabet Med. 2012 Jul;29(7):855-62
pubmed: 22537247
Diabetes Care. 2013 Apr;36(4):1033-46
pubmed: 23468086
Endocr Pract. 2014 Sep;20(9):870-5
pubmed: 24641928
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
Int J Technol Assess Health Care. 2016 Jan;32(6):400-406
pubmed: 28065172
J Diabetes Complications. 2014 Jul-Aug;28(4):427-9
pubmed: 24813860
Commun Dis Public Health. 2004 Mar;7(1):39-46
pubmed: 15137280
Diabet Med. 2015 Apr;32(4):459-66
pubmed: 25439048

Auteurs

Ric Fordham (R)

The Health Economics Group, University of East Anglia Norwich Medical School, Norwich, UK.

Ketan Dhatariya (K)

Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK ketan.dhatariya@nnuh.nhs.uk.
Norwich Medical School, University of East Anglia, Norwich, UK.

Rachel Stancliffe (R)

Centre for Sustainable Healthcare, Oxford, UK.

Adam Lloyd (A)

Health Economics and Outcomes Research, IQVIA UK, London, UK.

Mou Chatterjee (M)

Health Economics and Outcomes Research, IQVIA, Gurgaon, India.

Mevin Mathew (M)

Health Economics and Outcomes Research, IQVIA, Gurgaon, India.

Loveleen Taneja (L)

Health Economics and Outcomes Research, IQVIA, Gurgaon, India.

Mike Gains (M)

Health Economics and Outcomes Research, IQVIA UK, London, UK.

Ulrik Haagen Panton (U)

Evidence Generation, Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH